GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) » Definitions » Cyclically Adjusted PB Ratio

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Cyclically Adjusted PB Ratio : 1.96 (As of Sep. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-09-25), Shanghai Kaibao Pharmaceutical Co's current share price is ¥5.34. Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was ¥2.72. Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.96.

The historical rank and industry rank for Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:300039' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.84   Med: 2.64   Max: 5.34
Current: 1.85

During the past years, Shanghai Kaibao Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 5.34. The lowest was 1.84. And the median was 2.64.

SZSE:300039's Cyclically Adjusted PB Ratio is ranked worse than
52.56% of 567 companies
in the Drug Manufacturers industry
Industry Median: 1.79 vs SZSE:300039: 1.85

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Kaibao Pharmaceutical Co's adjusted book value per share data for the three months ended in Jun. 2024 was ¥3.355. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥2.72 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Shanghai Kaibao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.60 2.39 2.81 3.31 2.52

Shanghai Kaibao Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.73 2.64 2.52 2.27 1.97

Competitive Comparison of Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.34/2.72
=1.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Shanghai Kaibao Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=3.355/114.7809*114.7809
=3.355

Current CPI (Jun. 2024) = 114.7809.

Shanghai Kaibao Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201409 1.611 98.900 1.870
201412 1.744 99.000 2.022
201503 1.827 99.900 2.099
201506 1.808 99.500 2.086
201509 1.869 100.500 2.135
201512 1.850 100.600 2.111
201603 1.937 102.200 2.175
201606 1.961 101.400 2.220
201609 2.024 102.400 2.269
201612 2.041 102.600 2.283
201703 2.125 103.200 2.363
201706 2.235 103.100 2.488
201709 2.200 104.100 2.426
201712 2.208 104.500 2.425
201803 2.301 105.300 2.508
201806 2.279 104.900 2.494
201809 2.330 106.600 2.509
201812 2.329 106.500 2.510
201903 2.373 107.700 2.529
201906 2.330 107.700 2.483
201909 2.421 109.800 2.531
201912 2.456 111.200 2.535
202003 2.507 112.300 2.562
202006 2.430 110.400 2.526
202009 2.458 111.700 2.526
202012 2.465 111.500 2.538
202103 2.520 112.662 2.567
202106 2.513 111.769 2.581
202109 2.902 112.215 2.968
202112 2.911 113.108 2.954
202203 3.070 114.335 3.082
202206 4.220 114.558 4.228
202209 3.534 115.339 3.517
202212 3.596 115.116 3.586
202303 3.935 115.116 3.924
202306 3.719 114.558 3.726
202309 3.653 115.339 3.635
202312 3.854 114.781 3.854
202403 3.612 115.227 3.598
202406 3.355 114.781 3.355

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Kaibao Pharmaceutical Co  (SZSE:300039) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kaibao Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone, Shanghai, CHN, 201401
Shanghai Kaibao Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in research, development, production, and sales of modern Chinese medicine. The company produces traditional Chinese medicines in the form of solid dosage, oral liquids, and small volume injections. Its main product is Tanreqing injection is mainly used for pneumonia, acute and chronic bronchitis and upper respiratory tract infection.
Executives
Liu Shao Yong Supervisors
Ren Li Wang Secretary Dong
Zhang Tao Executives
Mu Jing Wei Director
Li Xiu Hai Directors, executives
Zhang Lian Xin Supervisors
Han Jing Independent director
Wang Guo Ming Directors, executives
Wang Chong Bang Executives
Liu Yi Shan Director
Li Qing Wei Independent director
Mu Lai An Director
Zhu Ying Jun Executives
Chang Qing Ling Supervisors
Zhang Peng Director

Shanghai Kaibao Pharmaceutical Co Headlines

No Headlines